Cellectis (CLLS) Divestments (2016 - 2024)
Cellectis (CLLS) posted quarterly Divestments of -$18000.0 for Q2 2023, up 95.98% year-over-year from -$9184.5 in Q2 2022, and down 118.56% quarter-over-quarter from $97000.0 in Q1 2023.
Powered by 
Analysis
Cellectis (CLLS) Divestments (2016 - 2024) Analysis & Trends
Cellectis' Divestments history runs 2 years deep, the most recent figure standing at -$18000.0 for Q2 2023.
- In Q2 2023, Divestments rose 95.98% year-over-year to -$18000.0; the TTM figure through Dec 2023 stood at $79000.0 (up 117.71% YoY), while the FY2023 annual figure was $79000.0, up 117.71% from the prior year.
- Divestments for Q2 2023 stood at -$18000.0, down from $97000.0 in the prior quarter.
- The five-year high for Divestments was $177000.0 in Q3 2022, with the low at -$448000.0 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -105.39 Mn |
| Mar 31, 2024 | -1.69 Mn |
| Sep 30, 2023 | 79,000.00 |
| Jun 30, 2023 | -97,000.00 |
| Mar 31, 2023 | 97,000.00 |
| Dec 31, 2022 | 121,000.00 |
| Sep 30, 2022 | -567,000.00 |
| Jun 30, 2022 | 296,000.00 |
| Mar 31, 2022 | -296,000.00 |
| Dec 31, 2021 | -11.70 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 15.05 Mn |
| Mar 31, 2021 | 8.65 Mn |
| Dec 31, 2020 | 25.85 Mn |
| Sep 30, 2020 | 9.14 Mn |
| Jun 30, 2020 | 8.63 Mn |
| Mar 31, 2020 | -38.62 Mn |
| Dec 31, 2019 | 148,000.00 |
| Sep 30, 2019 | -20.00 Mn |
| Jun 30, 2019 | -1,000.00 |